{"id":59819,"date":"2016-09-14T15:59:35","date_gmt":"2016-09-14T15:59:35","guid":{"rendered":"https:\/\/leitat.org\/blog\/nanonafres\/"},"modified":"2025-02-24T20:34:48","modified_gmt":"2025-02-24T20:34:48","slug":"nanonafres","status":"publish","type":"post","link":"https:\/\/leitat.org\/en\/blog\/nanonafres\/","title":{"rendered":"NANONAFRES"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"59819\" class=\"elementor elementor-59819 elementor-10024\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2fedc6a9 e-flex e-con-boxed e-con e-parent\" data-id=\"2fedc6a9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b075d3f elementor-widget elementor-widget-text-editor\" data-id=\"b075d3f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4>NANONAFRES<\/h4><p><strong>Preclinical and Clinical Studies of Nanovesicles (Quatsomes) with EGF for Chronic Venous Ulcers<\/strong><\/p><p><strong>Objective:<\/strong><br \/>Conduct preclinical studies and clinical trials to evaluate the application of nanovesicles containing epidermal growth factor (EGF) administered topically to patients with chronic venous ulcers. The goal is to facilitate epithelialization and ulcer closure.<\/p><p><strong>Innovation:<\/strong><br \/>Development of an innovative vehicle for delivering the active ingredient.<\/p><p><strong>Expected Result:<\/strong><br \/>Progress to the clinical phase of development and creation of a prototype for testing.<\/p><ul><li><strong>Project Budget:<\/strong> \u20ac2,300,000<\/li><li><strong>Financial Framework:<\/strong> RIS3CAT<\/li><li><strong>Contract Number:<\/strong> COMRDI15-1-0023-03<\/li><li><strong>Start Date:<\/strong> 15\/10\/2016<\/li><li><strong>End Date:<\/strong> 15\/10\/2019<\/li><\/ul><h3>Partners:<\/h3><figure class=\"gallery-item\"><img decoding=\"async\" class=\"alignnone size-full wp-image-40507\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/nanomol-logo3-300x143-1.png\" alt=\"\" width=\"300\" height=\"143\" \/><br \/><figcaption id=\"gallery-3-10027\" class=\"wp-caption-text gallery-caption\">Coordinator<\/figcaption><\/figure><figure class=\"gallery-item\"><img decoding=\"async\" class=\"alignnone size-full wp-image-40508\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/osonasud-350x116-1.png\" alt=\"\" width=\"350\" height=\"116\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/osonasud-350x116-1.png 350w, https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/osonasud-350x116-1-300x99.png 300w\" sizes=\"(max-width: 350px) 100vw, 350px\" \/><\/figure><figure class=\"gallery-item\"><img decoding=\"async\" class=\"alignnone size-full wp-image-40509\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/CST.jpg\" alt=\"\" width=\"300\" height=\"138\" \/><\/figure><figure class=\"gallery-item\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-40510\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/Fundacio-Salut-Maresme-350x200-1.png\" alt=\"\" width=\"350\" height=\"200\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/Fundacio-Salut-Maresme-350x200-1.png 350w, https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/Fundacio-Salut-Maresme-350x200-1-300x171.png 300w\" sizes=\"(max-width: 350px) 100vw, 350px\" \/><\/figure><figure class=\"gallery-item\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-40511\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/logo_apvsg_web.jpg_1701775036.jpg\" alt=\"\" width=\"331\" height=\"80\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/logo_apvsg_web.jpg_1701775036.jpg 331w, https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/logo_apvsg_web.jpg_1701775036-300x73.jpg 300w\" sizes=\"(max-width: 331px) 100vw, 331px\" \/><\/figure><figure class=\"gallery-item\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-40512\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/OCHOA_CSIC-COLOR_Transparencia-350x174-1.png\" alt=\"\" width=\"350\" height=\"174\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/OCHOA_CSIC-COLOR_Transparencia-350x174-1.png 350w, https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/OCHOA_CSIC-COLOR_Transparencia-350x174-1-300x149.png 300w\" sizes=\"(max-width: 350px) 100vw, 350px\" \/><\/figure><figure class=\"gallery-item\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-40513\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/Leitat_ppt-200.png\" alt=\"\" width=\"200\" height=\"76\" \/><\/figure><p><strong>Contact Manager:<\/strong> <a href=\"mailto:mgimenez@leitat.org\">M. Gimenez<\/a><\/p><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-40514\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/Logo-FEDER-1024x185-1.png\" alt=\"\" width=\"1024\" height=\"185\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/Logo-FEDER-1024x185-1.png 1024w, https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/Logo-FEDER-1024x185-1-300x54.png 300w, https:\/\/leitat.org\/wp-content\/uploads\/2024\/12\/Logo-FEDER-1024x185-1-768x139.png 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/p><p>This project has received funding from the European Union through the European Regional Development Funds (ERDF).<\/p><p><strong>Objectiu:<\/strong> Promoure el desenvolupament tecnol\u00f2gic, la innovaci\u00f3 i una investigaci\u00f3 de qualitat.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>NANONAFRES Preclinical and Clinical Studies of Nanovesicles (Quatsomes) with EGF for Chronic Venous Ulcers Objective: Conduct preclinical studies and clinical trials to evaluate the application of nanovesicles containing epidermal growth factor (EGF) administered topically to patients with chronic venous ulcers. The goal is to facilitate epithelialization and ulcer closure. Innovation: Development of an innovative vehicle [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":52237,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[142,152],"tags":[112],"class_list":["post-59819","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-technologies-en","category-ris3cat-en","tag-projects"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NANONAFRES - Leitat Technological Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NANONAFRES - Leitat Technological Center\" \/>\n<meta property=\"og:description\" content=\"NANONAFRES Preclinical and Clinical Studies of Nanovesicles (Quatsomes) with EGF for Chronic Venous Ulcers Objective: Conduct preclinical studies and clinical trials to evaluate the application of nanovesicles containing epidermal growth factor (EGF) administered topically to patients with chronic venous ulcers. The goal is to facilitate epithelialization and ulcer closure. Innovation: Development of an innovative vehicle [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leitat.org\/en\/blog\/nanonafres\/\" \/>\n<meta property=\"og:site_name\" content=\"Leitat Technological Center\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-14T15:59:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-24T20:34:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"656\" \/>\n\t<meta property=\"og:image:height\" content=\"379\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Comunicaci\u00f3n Leitat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunicaci\u00f3n Leitat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/\"},\"author\":{\"name\":\"Comunicaci\u00f3n Leitat\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131\"},\"headline\":\"NANONAFRES\",\"datePublished\":\"2016-09-14T15:59:35+00:00\",\"dateModified\":\"2025-02-24T20:34:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/\"},\"wordCount\":128,\"publisher\":{\"@id\":\"https:\/\/leitat.org\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg\",\"keywords\":[\"Projects\"],\"articleSection\":[\"Health technologies\",\"RIS3CAT\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/\",\"url\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/\",\"name\":\"NANONAFRES - Leitat Technological Center\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg\",\"datePublished\":\"2016-09-14T15:59:35+00:00\",\"dateModified\":\"2025-02-24T20:34:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/leitat.org\/en\/blog\/nanonafres\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/#primaryimage\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg\",\"width\":656,\"height\":379},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/nanonafres\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"HOME\",\"item\":\"https:\/\/leitat.org\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Health technologies\",\"item\":\"https:\/\/leitat.org\/en\/blog\/category\/health-technologies-en\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"NANONAFRES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/leitat.org\/en\/#website\",\"url\":\"https:\/\/leitat.org\/en\/\",\"name\":\"Leitat Technological Center\",\"description\":\"Managing Technologies\",\"publisher\":{\"@id\":\"https:\/\/leitat.org\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/leitat.org\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/leitat.org\/en\/#organization\",\"name\":\"Leitat Technological Center\",\"url\":\"https:\/\/leitat.org\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"width\":226,\"height\":78,\"caption\":\"Leitat Technological Center\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131\",\"name\":\"Comunicaci\u00f3n Leitat\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"caption\":\"Comunicaci\u00f3n Leitat\"},\"sameAs\":[\"https:\/\/leitat.org\"],\"url\":\"https:\/\/leitat.org\/en\/blog\/author\/comunica-wp\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NANONAFRES - Leitat Technological Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"NANONAFRES - Leitat Technological Center","og_description":"NANONAFRES Preclinical and Clinical Studies of Nanovesicles (Quatsomes) with EGF for Chronic Venous Ulcers Objective: Conduct preclinical studies and clinical trials to evaluate the application of nanovesicles containing epidermal growth factor (EGF) administered topically to patients with chronic venous ulcers. The goal is to facilitate epithelialization and ulcer closure. Innovation: Development of an innovative vehicle [&hellip;]","og_url":"https:\/\/leitat.org\/en\/blog\/nanonafres\/","og_site_name":"Leitat Technological Center","article_published_time":"2016-09-14T15:59:35+00:00","article_modified_time":"2025-02-24T20:34:48+00:00","og_image":[{"width":656,"height":379,"url":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg","type":"image\/jpeg"}],"author":"Comunicaci\u00f3n Leitat","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Comunicaci\u00f3n Leitat","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/#article","isPartOf":{"@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/"},"author":{"name":"Comunicaci\u00f3n Leitat","@id":"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131"},"headline":"NANONAFRES","datePublished":"2016-09-14T15:59:35+00:00","dateModified":"2025-02-24T20:34:48+00:00","mainEntityOfPage":{"@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/"},"wordCount":128,"publisher":{"@id":"https:\/\/leitat.org\/en\/#organization"},"image":{"@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg","keywords":["Projects"],"articleSection":["Health technologies","RIS3CAT"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/","url":"https:\/\/leitat.org\/en\/blog\/nanonafres\/","name":"NANONAFRES - Leitat Technological Center","isPartOf":{"@id":"https:\/\/leitat.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/#primaryimage"},"image":{"@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg","datePublished":"2016-09-14T15:59:35+00:00","dateModified":"2025-02-24T20:34:48+00:00","breadcrumb":{"@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leitat.org\/en\/blog\/nanonafres\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/#primaryimage","url":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg","width":656,"height":379},{"@type":"BreadcrumbList","@id":"https:\/\/leitat.org\/en\/blog\/nanonafres\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"HOME","item":"https:\/\/leitat.org\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Health technologies","item":"https:\/\/leitat.org\/en\/blog\/category\/health-technologies-en\/"},{"@type":"ListItem","position":3,"name":"NANONAFRES"}]},{"@type":"WebSite","@id":"https:\/\/leitat.org\/en\/#website","url":"https:\/\/leitat.org\/en\/","name":"Leitat Technological Center","description":"Managing Technologies","publisher":{"@id":"https:\/\/leitat.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leitat.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/leitat.org\/en\/#organization","name":"Leitat Technological Center","url":"https:\/\/leitat.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","width":226,"height":78,"caption":"Leitat Technological Center"},"image":{"@id":"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131","name":"Comunicaci\u00f3n Leitat","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","caption":"Comunicaci\u00f3n Leitat"},"sameAs":["https:\/\/leitat.org"],"url":"https:\/\/leitat.org\/en\/blog\/author\/comunica-wp\/"}]}},"_links":{"self":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/59819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/comments?post=59819"}],"version-history":[{"count":1,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/59819\/revisions"}],"predecessor-version":[{"id":59850,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/59819\/revisions\/59850"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/media\/52237"}],"wp:attachment":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/media?parent=59819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/categories?post=59819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/tags?post=59819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}